Invivyd IVVD
NASDAQ IVVD
$0.60 -0.04 (-6.48%)
As of: Oct 22, 2026 · 12:46 PM EDT

Invivyd (IVVD) EBIT Margin (2024 - 2026)

Updated

Invivyd's EBIT Margin came in at -320.76% for Q2 2026, down 192.98 percentage points from -127.78% a year earlier.

Analysis

Invivyd (IVVD) EBIT Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Invivyd reported EBIT Margin of -149.73%, up 95.94 percentage points year-over-year; for FY2025, it came in at -103.99%, up 592.81 percentage points from FY2024.

  • Going back by year, EBIT Margin was -696.80% in FY2024.
  • The Q2 2026 figure represents the lowest quarterly EBIT Margin since Q3 2024.
  • Year-over-year, EBIT Margin increased in three of the last four quarters, with an average year-over-year change of +626.67 percentage points.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,169.59 Bn 1,138.18 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 643.18 Bn 561.71 Bn 17.26 Bn 28.21%
3 AbbVie 500.89 Bn 474.00 Bn 12.70 Bn 37.86%
4 Merck 361.55 Bn 315.92 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.33 Bn 266.32 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.31 Bn 241.00 Bn 12.86 Bn 20.57%
7 Amgen 241.52 Bn 196.92 Bn 7.24 Bn 34.95%
8 Gilead Sciences 193.17 Bn 167.37 Bn 6.22 Bn -133.21%
9 Pfizer 171.65 Bn 118.30 Bn 10.94 Bn 28.37%
10 Invivyd 191.52 Mn -315.12 Mn 13.01 Mn -320.76%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -320.76%
Dec 31, 2025 -72.96%
Sep 30, 2025 -83.96%
Jun 30, 2025 -127.78%
Mar 31, 2025 -149.70%
Dec 31, 2024 -139.14%
Sep 30, 2024 -670.01%
Jun 30, 2024 -2,175.22%
API Access

Invivyd EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=IVVD&period=max&api_key=YOUR_API_KEY